Syndax Pharmaceuticals, Inc. (SNDX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SNDX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 232 institutions reported holding SNDX, with 107.6 million shares worth $2.4 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 9,020,006 | $197M | INCREASED |
| Kynam Capital Management | 8,050,959 | $176M | UNCHANGED |
| Vanguard | 6,595,559 | $144M | INCREASED |
| Goldman Sachs | 5,861,265 | $128M | INCREASED |
| State Street | 5,658,424 | $124M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Syndax Pharmaceuticals, Inc. on SentiSense.